单位:[1]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China[2]Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Tongji Hosp, Dept Biliary Pancreat Surg, Wuhan 430030, Hubei, Peoples R China华中科技大学同济医学院附属同济医院[3]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China[4]Chinese Acad Med Sci & Peking Union Med Coll, Clin Immunol Ctr, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China
第一作者单位:[1]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China[2]Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Tongji Hosp, Dept Biliary Pancreat Surg, Wuhan 430030, Hubei, Peoples R China
通讯作者:
通讯机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China[4]Chinese Acad Med Sci & Peking Union Med Coll, Clin Immunol Ctr, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
Xiong Guangbing,Huang Hua,Feng Mengyu,et al.MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma (vol 37, 76, 2018)[J].JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH.2021,40(1):doi:10.1186/s13046-021-02152-w.
APA:
Xiong, Guangbing,Huang, Hua,Feng, Mengyu,Yang, Gang,Zheng, Suli...&Zhao, Yupei.(2021).MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma (vol 37, 76, 2018).JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,40,(1)
MLA:
Xiong, Guangbing,et al."MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma (vol 37, 76, 2018)".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 40..1(2021)